Consistent with published reports on CASC2/mir-21 interaction in glioma and non-small cell lung cancer cells in vitro [20,24], we provide evidence in patient gliomas that CASC2 and miR-21 play antagonistic roles and potentially interact in glioma progression. This evidence concerns the gene CASC2 and non-small cell lung carcinoma.